|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1995-5-18
|
|
pubmed:abstractText |
Sera from 22 (84.6%) of 26 patients with confirmed Aspergillus infections recognized a purified Cu,Zn superoxide dismutase from A. fumigatus on Western blots (immunoblots). Sera from 32 (71%) of 45 patients with suspected Aspergillus infections were reactive to the superoxide dismutase. Normal human sera and sera from patients with other infections were unreactive.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0095-1137
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
495-6
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera.
|
|
pubmed:affiliation |
Dermatology Laboratory, St. Johns' Institute, Guys Hospital, London, England.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
